Trader 📈 bio-hacker 🧬 and weight lifter 💪🏼 Peptides are the future. Disclosure: Opinions only, not investment advice. DYOR. High risk, High reward stocks.
$AZN$LEXX AstraZeneca and Zealand Pharma are in an existential commercial crisis right now with their announced catastrophic tolerability in their GLP1 studies. Nausea, vomiting and diarrhea. High drops out rates. @AstraZeneca
As speculated, the mystery global pharma in the MTA is @EliLillyandCo or @novonordisk they should be worried about another player swooping in. 🔥
$NVO / $LLY
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology”
Key words “utilizing our partners API” 👀
$NVO / $LLY
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology”
Key words “utilizing our partners API” 👀
$NVO / $LLY
$AZN$LEXX AstraZeneca and Zealand Pharma are in an existential commercial crisis right now with their announced catastrophic tolerability in their GLP1 studies. Nausea, vomiting and diarrhea. High drops out rates. @AstraZeneca
As speculated, the mystery global pharma in the MTA is @EliLillyandCo or @novonordisk they should be worried about another player swooping in. 🔥
$NVO / $LLY
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology”
Key words “utilizing our partners API” 👀
$NVO / $LLY
$LEXX Quote from CEO Richard Christopher in video regarding MTA: “what I can tell you is that they are a worldwide global glp1 player….We have now completed two distinct animals studies utilizing our partners API along with our dehydraTECH technology”
Key words “utilizing our partners API” 👀
$NVO / $LLY
$AZN 👀 $LEXX “Gastrointestinal side effects were common at the highest dose, including nausea (55%), constipation (41%), diarrhea (35%), and vomiting (27%), although AstraZeneca said discontinuation rates were low.”
$AZN$ZEAL
AstraZeneca and Zealand Pharma are in an existential commercial crisis right now with their announced catastrophic tolerability in their GLP1 studies. Nausea, vomiting and diarrhea. High drops out rates. @AstraZeneca
Hard to imagine they are not knocking on @LexariaBioCorp door right now.
$LEXX dehydraTECH 👀
$AZN 👀 $LEXX “Gastrointestinal side effects were common at the highest dose, including nausea (55%), constipation (41%), diarrhea (35%), and vomiting (27%), although AstraZeneca said discontinuation rates were low.”